OCO Biomedical to present ‘The Next Generation of Dental Implant Technology’ at AAID meeting

Schlesinger’s lecture will cover the impact of osseous fixation and implant choice and how this process expedites immediate-loading capabilities, which allows practitioners to predictably restore an implant in a short period of time.

In addition to Schlesinger’s lecture, OCO Biomedical Inc., a global leader in implant dentistry products, technology and training, will showcase “The OCO Advantage: A Complete Dental Implant Solutions Approach,” featuring the company’s updated product line and innovations in technology.

Information about the expanded AGD-Pace accredited 2014-15 educational courses, workshops and registration discounts for AAID participants to the upcoming 2015 OCO Biomedical International Implant Symposium will also be available.

Official exhibition hours are Thursday, Nov. 6, from 9:30 a.m.–7 p.m., Friday, Nov. 7, from 9:30 a.m.–5 p.m. and Saturday, Nov. 8, from 9:30 a.m.–1 p.m.

“OCO Biomedical has always emphasized the critical importance of continuing education for practitioners to improve patient care and build practice performance,” Schlesinger said. “Over the years, based on our constant research and assessment of the ever-evolving needs of the dental community and, given the fact that implant dentistry is now one of the fastest growing segments within the industry, OCO remains totally committed to providing practitioners with cutting-edge products, technology and training excellence essential to success in this very competitive field.

“OCO’s entire program is designed by dentists for dentists. We look forward to sharing our exciting, new developments again this year with our many AAID colleagues and associates.”

In addition to OCO’s lecture and exhibition, the company has announced that Schlesinger and OCO Biomedical’s Founder and President David D. Dalise, DDS, will be available at the AAID meeting for mentoring and consultation as schedules permit.

Instructor biography: Charles Schlesinger, DDS, FICOI

Schlesinger is a nationally recognized speaker, prolific clinical author and OCO chief operating officer/director of education and clinical affairs. He graduated from the Ohio State University College of Dentistry in 1996 and completed a general practice residency at the VAMC San Diego. He then went on to become the chief resident of the GPR program at the VAMC W Los Angeles. While at VAMC, he received extensive training in oral surgery, implantology and complex restorative dentistry. Schlesinger maintained a private practice in San Diego prior to assuming his executive duties at OCO Biomedical, Inc., headquartered in Albuquerque, N.M.

Since 2007, Schlesinger has been an industry-leading implant educator, speaker and mentor, well-known throughout the dental community for his engaging, no-nonsense, practical lecture style and comprehensive, cutting-edge knowledge of implantology.

About OCO Biomedical Inc.

Established in 1977 and headquartered in Albuquerque, N.M., OCO Biomedical Inc. is a privately owned dental implant company. In addition to the company’s vast network of practitioners using OCO products in the United States, the company has an international network of distributors located in Asia, Central and South America, Europe and the Caribbean. OCO Biomedical is a world leader in creating and supplying patented, brand-name dental implant products, technology and AGD-Pace C.E. accredited education and training in North America. OCO Biomedical is a implant company that provides complete implant solutions, allowing practitioners to serve their patients effectively while simultaneously building practice performance.

(Source: OCO Biomedical)